rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2000-1-6
|
pubmed:abstractText |
Infection remains the single most important challenge to extended left ventricular assist device (LVAD) use and often arises from the percutaneous driveline exit site. We evaluated the ability of an LVAD driveline prototype impregnated with chlorhexidine, triclosan, and silver sulfadiazine to resist bacterial and fungal colonization.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1053-2498
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1103-10
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10598734-Animals,
pubmed-meshheading:10598734-Bacteria,
pubmed-meshheading:10598734-Bacterial Infections,
pubmed-meshheading:10598734-Colony Count, Microbial,
pubmed-meshheading:10598734-Equipment Contamination,
pubmed-meshheading:10598734-Equipment Design,
pubmed-meshheading:10598734-Evaluation Studies as Topic,
pubmed-meshheading:10598734-Female,
pubmed-meshheading:10598734-Heart-Assist Devices,
pubmed-meshheading:10598734-Prosthesis Design,
pubmed-meshheading:10598734-Prosthesis-Related Infections,
pubmed-meshheading:10598734-Rats,
pubmed-meshheading:10598734-Rats, Sprague-Dawley
|
pubmed:year |
1999
|
pubmed:articleTitle |
Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections.
|
pubmed:affiliation |
Department of Surgery, Columbia University, New York, New York, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|